Search results: Sage Journals

Open accessBrief reportFirst published 2025

Ketamine dosing formula in treatment-resistant bipolar depression

Aleksander Kwaśny, Wiesław Jerzy Cubała, Alina Wilkowska

Therapeutic Advances in Psychopharmacology

Open accessBrief reportFirst published 2026

Anhedonia nonresponse to short-term ketamine administration for treatment-resistant bipolar depression

Zofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek [...]

Therapeutic Advances in Psychopharmacology

Available accessResearch articleFirst published February, 2021

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence

Roger S McIntyre, Nelson B Rodrigues, Orly Lipsitz [...]

Journal of Psychopharmacology

Free accessResearch articleFirst published June, 1995

A Comparison of Comorbid Patterns in Treatment-Resistant Unipolar and Bipolar Depression

Verinder Sharma, Dwight Mazmanian, Emmanuel Persad [...]

The Canadian Journal of Psychiatry

Open accessResearch articleFirst published February, 2025

A randomised double-blind,placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)

R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim [...]

Journal of Psychopharmacology

Retricted accessResearch articleFirst published February, 2011

Lamotrigine plus Quetiapine Combination Therapy in Treatment-Resistant Bipolar Depression

Yong M. Ahn, Jennifer Y. Nam, Jenifer L. Culver [...]

Annals of Clinical Psychiatry

Retricted accessResearch articleFirst published March, 2025

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder

Shakila Meshkat, Erica Kaczmarek, Zoe Doyle [...]

Psychedelic Medicine

Free accessReview articleFirst published April, 2017

Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain

Álvaro López-Díaz, José Luis Fernández-González, José Evaristo Luján-Jiménez [...]

Therapeutic Advances in Psychopharmacology

Open accessResearch articleFirst published 2021

Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression

Adam Włodarczyk, Wiesław J. Cubała, Maria Gałuszko-Węgielnik [...]

Therapeutic Advances in Psychopharmacology

Open accessReview articleFirst published 2026

Patient-centred education for ketamine and esketamine therapies in mood disorders

Zofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek

Therapeutic Advances in Psychopharmacology

Open accessBrief reportFirst published 2025

Ketamine dosing formula in treatment-resistant bipolar depression

Aleksander Kwaśny, Wiesław Jerzy Cubała, Alina Wilkowska

Therapeutic Advances in Psychopharmacology

Open accessBrief reportFirst published 2026

Anhedonia nonresponse to short-term ketamine administration for treatment-resistant bipolar depression

Zofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek [...]

Therapeutic Advances in Psychopharmacology

Available accessResearch articleFirst published February, 2021

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence

Roger S McIntyre, Nelson B Rodrigues, Orly Lipsitz [...]

Journal of Psychopharmacology

Free accessResearch articleFirst published June, 1995

A Comparison of Comorbid Patterns in Treatment-Resistant Unipolar and Bipolar Depression

Verinder Sharma, Dwight Mazmanian, Emmanuel Persad [...]

The Canadian Journal of Psychiatry

Open accessResearch articleFirst published February, 2025

A randomised double-blind,placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)

R Hamish McAllister-Williams, Nicola Goudie, Lumbini Azim [...]

Journal of Psychopharmacology

Retricted accessResearch articleFirst published February, 2011

Lamotrigine plus Quetiapine Combination Therapy in Treatment-Resistant Bipolar Depression

Yong M. Ahn, Jennifer Y. Nam, Jenifer L. Culver [...]

Annals of Clinical Psychiatry

Retricted accessResearch articleFirst published March, 2025

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder

Shakila Meshkat, Erica Kaczmarek, Zoe Doyle [...]

Psychedelic Medicine

Free accessReview articleFirst published April, 2017

Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain

Álvaro López-Díaz, José Luis Fernández-González, José Evaristo Luján-Jiménez [...]

Therapeutic Advances in Psychopharmacology

Open accessResearch articleFirst published 2021

Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression

Adam Włodarczyk, Wiesław J. Cubała, Maria Gałuszko-Węgielnik [...]

Therapeutic Advances in Psychopharmacology

Open accessReview articleFirst published 2026

Patient-centred education for ketamine and esketamine therapies in mood disorders

Zofia Kachlik, Wiesław Jerzy Cubała, Michał Walaszek

Therapeutic Advances in Psychopharmacology